SCHEMBL12568917

SCHEMBL12568917

C=C[C@H]1[C@H](Cl)CCN1B(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12568916 0.81 — —
SCHEMBL11990429 0.72 CHRNB2 (0.35) —
SCHEMBL12568911 0.68 GBA1 (0.33) —
SCHEMBL11990433 0.66 CHRNB2 (0.36) —
SCHEMBL17414365 0.65 — —
SCHEMBL11990436 0.64 CHRNB2 (0.42) —
SCHEMBL17414354 0.64 — —
SCHEMBL17414363 0.63 — —
SCHEMBL17414353 0.60 CHRNB2 (0.32) —
SCHEMBL11990387 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964596-B2 Therapeutic compounds ALLERGAN, INC. (US) 2011-06-21 — — US disclosed
US-20090227635-A1 THERAPEUTIC COMPOUNDS ALLERGAN, INC. (US) 2009-09-10 — — US disclosed
Send feedback